Minimal Access Tricuspid Valve Surgery

J Cardiovasc Dev Dis. 2023 Mar 13;10(3):118. doi: 10.3390/jcdd10030118.

Abstract

Tricuspid valve diseases are a heterogeneous group of pathologies that typically have poor prognoses when treated medically and are associated with significant morbidity and mortality with traditional surgical techniques. Minimal access tricuspid valve surgery may mitigate some of the surgical risks associated with the standard sternotomy approach by limiting pain, reducing blood loss, lowering the risk of wound infections, and shortening hospital stays. In certain patient populations, this may allow for a prompt intervention that could limit the pathologic effects of these diseases. Herein, we review the literature on minimal access tricuspid valve surgery focusing on perioperative planning, technique, and outcomes of minimal access endoscopic and robotic surgery for isolated tricuspid valve disease.

Keywords: endoscopic and robotic cardiac surgery; minimal access surgery; tricuspid valve regurgitation.

Publication types

  • Review

Grants and funding

This research received no external funding.